Lyell Immunopharma (LYEL) Accumulated Expenses: 2020-2025
Historic Accumulated Expenses for Lyell Immunopharma (LYEL) over the last 5 years, with Sep 2025 value amounting to $29.3 million.
- Lyell Immunopharma's Accumulated Expenses rose 1.04% to $29.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.3 million, marking a year-over-year increase of 1.04%. This contributed to the annual value of $40.8 million for FY2024, which is 45.14% up from last year.
- According to the latest figures from Q3 2025, Lyell Immunopharma's Accumulated Expenses is $29.3 million, which was up 4.68% from $28.0 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Accumulated Expenses ranged from a high of $40.8 million in Q4 2024 and a low of $21.4 million during Q2 2022.
- Over the past 3 years, Lyell Immunopharma's median Accumulated Expenses value was $28.1 million (recorded in 2023), while the average stood at $28.5 million.
- Per our database at Business Quant, Lyell Immunopharma's Accumulated Expenses fell by 16.32% in 2022 and then soared by 45.14% in 2024.
- Over the past 5 years, Lyell Immunopharma's Accumulated Expenses (Quarterly) stood at $29.1 million in 2021, then dropped by 1.04% to $28.8 million in 2022, then decreased by 2.19% to $28.1 million in 2023, then surged by 45.14% to $40.8 million in 2024, then rose by 1.04% to $29.3 million in 2025.
- Its last three reported values are $29.3 million in Q3 2025, $28.0 million for Q2 2025, and $31.2 million during Q1 2025.